Citation Impact
Citing Papers
Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade
2017 Standout
Cyclooxygenase‐2‐positive macrophages infiltrate the Alzheimer’s disease brain and damage the blood–brain barrier
2002
Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease
2005
Drug treatments in Alzheimer’s disease
2016
Mohs micrographic surgery: A cost analysis
1998
Drug development in Alzheimer’s disease: the path to 2025
2016
The effects of regional climatic condition on the spread of COVID-19 at global scale
2020
Mechanisms, regulation and functions of the unfolded protein response
2020 Standout
Do Certain Atypical Antipsychotics Increase the Risk of Diabetes? A Critical Review of 17 Pharmacoepidemiologic Studies
2006
The Homeodomain Protein Arix Interacts Synergistically with Cyclic AMP to Regulate Expression of Neurotransmitter Biosynthetic Genes
1997
Affibody-Mediated Sequestration of Amyloid β Demonstrates Preventive Efficacy in a Transgenic Alzheimer’s Disease Mouse Model
2019
Cell interactions coordinate the development of the C. elegans egg-laying system
1990 StandoutNobel
The central role of hypothalamic inflammation in the acute illness response and cachexia
2015
On the path to 2025: understanding the Alzheimer’s disease continuum
2017
Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease
2014
The Blood-Brain Barrier/Neurovascular Unit in Health and Disease
2005 Standout
Metabolic Issues in Patients with Severe Mental Illness
2005
Microbiota and SCFA in Lean and Overweight Healthy Subjects
2009 Standout
Environmental Risk Factors and Parkinson's Disease: Selective Degeneration of Nigral Dopaminergic Neurons Caused by the Herbicide Paraquat
2002 Standout
Nocardiosis: Updated Clinical Review and Experience at a Tertiary Center
2010 Standout
The incidence of diabetes in atypical antipsychotic users differs according to agent—results from a multisite epidemiologic study
2009
Association between antipsychotic drugs and diabetes
2005
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
2018 Standout
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Long-term treatment of schizophrenia
2006
A synaptic model of memory: long-term potentiation in the hippocampus
1993 StandoutNature
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
Cancer-associated cachexia
2018 Standout
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Glucocorticoids and the Th1/Th2 Balance
2004
Alzheimer’s Disease
2012
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
2012 Standout
Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma
2009 Standout
Temporal Dynamics of Degenerative and Regenerative Events Associated with Cerebral Ischemia in Aged Rats
2003
Activation of Tyrosine Hydroxylase by Nicotine in Rat Adrenal Gland
1991
Alzheimer's disease
2016 Standout
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup
2011
Interrelation of inflammation and APP in sIBM: IL-1β induces accumulation of β-amyloid in skeletal muscle
2008
Aggressive basal cell carcinoma: Presentation, pathogenesis, and management
2004
Tumor necrosis factor‐α induces substance P in sympathetic ganglia through sequential induction of interleukin‐1 and leukemia inhibitory factor
1995
Blood-Brain Barrier Breakdown in the Aging Human Hippocampus
2015 Standout
Estimating the Risk of Drug-Induced Proarrhythmia Using Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes
2011
Comparing Tolerability of Olanzapine in Schizophrenia and Affective Disorders
2012
The pie-1 and mex-1 genes and maternal control of blastomere identity in early C. elegans embryos
1992 StandoutNobel
Obesity in Patients With Severe Mental Illness
2009
Design of amyloidogenic peptide traps
2024 StandoutNobel
Alzheimer Disease
2017
Haloperidol and clozapine, but not olanzapine, induces oxidative stress in rat brain
2004
IN VITRO EFFECTS OF ANTIPSYCHOTICS ON HUMAN PLATELET ADHESION AND AGGREGATION AND PLASMA COAGULATION
2007 StandoutNobel
Second-Generation (Atypical) Antipsychotics and Metabolic Effects
2005
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
2020 Standout
Chlorogentisylquinone, a New Neutral Sphingomyelinase Inhibitor, Produced by a Marine Fungus.
2001 StandoutNobel
The road to restoring neural circuits for the treatment of Alzheimer's disease
2016 Nature
Exploring the full spectrum of macrophage activation
2008 Standout
Drug‐Induced QT‐Interval Prolongation: Considerations for Clinicians
2010
Stimulus-induced coordinate changes in mRNA abundance in single postsynaptic hippocampal CA1 neurons
1992
Single-cell transcriptomic analysis of Alzheimer’s disease
2019 StandoutNature
Spatio-temporal reference model of Caenorhabditis elegans embryogenesis with cell contact maps
2009
The maternal gene skn-1 encodes a protein that is distributed unequally in early C. elegans embryos
1993 StandoutNobel
Cutaneous Squamous-Cell Carcinoma
2001 Standout
Comprehensive qPCR profiling of gene expression in single neuronal cells
2011 StandoutNobel
Metabolic side effects of antipsychotic medication
2007
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
Quantitative semi-automated analysis of morphogenesis with single-cell resolution in complex embryos
2012 StandoutNobel
Engineering Adolescence
2014 Standout
Lecanemab in Early Alzheimer’s Disease
2022 Standout
Vascular alterations in PDAPP mice after anti‐Aβ immunotherapy: Implications for amyloid‐related imaging abnormalities
2013
Inflammatory Muscle Diseases
2015 Standout
Schizophrenia, Obesity, and Antipsychotic Medications: What Can We Do?
2008
The neuropathological diagnosis of Alzheimer’s disease
2019 Standout
The Amyloid Cascade Hypothesis in Alzheimer’s Disease: It’s Time to Change Our Mind
2017
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Arcuate Nucleus Proopiomelanocortin Neurons Mediate the Acute Anorectic Actions of Leukemia Inhibitory Factor via gp130
2009
Principles of Experience-Dependent Neural Plasticity: Implications for Rehabilitation After Brain Damage
2008 Standout
Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis
2016 Standout
Determining clinically meaningful decline in preclinical Alzheimer disease
2019
Signal transduction of stress via ceramide
1998
Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia
2007
Coordinated Transcriptional Regulation of theunc-25Glutamic Acid Decarboxylase and theunc-47GABA Vesicular Transporter by theCaenorhabditis elegansUNC-30 Homeodomain Protein
1999 StandoutNobel
Inflammation as a central mechanism in Alzheimer's disease
2018 Standout
A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer’s disease dementia
2019
CD45 Opposes β-Amyloid Peptide-Induced Microglial Activation via Inhibition of p44/42 Mitogen-Activated Protein Kinase
2000
Risperidone versus other atypical antipsychotics for schizophrenia
2011
Pharmacological regulation of AP‐1 transcription factor DNA binding activity 1
1994
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Sphingolipids, Insulin Resistance, and Metabolic Disease: New Insights from in Vivo Manipulation of Sphingolipid Metabolism
2008
Emerging Therapeutics for Alzheimer's Disease
2014
Cellular and Molecular Dissection of Reperfusion Injury
2000 StandoutNobel
Religious Orders Study and Rush Memory and Aging Project
2018 Standout
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease
2018
Pluripotency and nuclear reprogramming
2008 StandoutNobel
Reversal of cellular polarity and early cell-cell interaction in the embryo of Caenorhabditis elegans
1987
Microglial M1/M2 polarization and metabolic states
2015 Standout
Switching to Aripiprazole as a Strategy for Weight Reduction: A Meta-Analysis in Patients Suffering from Schizophrenia
2010
Antioxidant and redox regulation of gene transcription
1996 Standout
The Sympathetic Nerve—An Integrative Interface between Two Supersystems: The Brain and the Immune System
2000 Standout
Risperidone versus placebo for schizophrenia
2016
The Metabolic Effects of Antipsychotic Medications
2006
Leukemia-Inhibitory Factor—Neuroimmune Modulator of Endocrine Function*
2000
Medications Associated with Weight Gain
2005
Industry sponsorship and research outcome
2017 Standout
The unfolded protein response in neurodegenerative disorders – therapeutic modulation of the PERK pathway
2018
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 Standout
Works of Christopher Carlson being referenced
Treatment of basal cell carcinoma and squamous cell carcinoma with perineural invasion.
1993
Stimulation of tyrosine hydroxylase gene transcription rate by nicotine in rat adrenal medulla.
1991
Improving the prediction of arbovirus outbreaks: A comparison of climate-driven models for West Nile virus in an endemic region of the United States
2018
Diabetes mellitus and antipsychotic treatment in the United Kingdom
2005
Activation of acidic sphingomyelinase and protein kinase C is required for IL-1 induction of LIF mRNA in a schwann cell line
1996
Retrospective analysis of risk factors in patients with treatment-emergent diabetes during clinical trials of antipsychotic medications
2004
An Integrated Analysis of Acute Treatment-Emergent Extrapyramidal Syndrome in Patients With Schizophrenia During Olanzapine Clinical Trials
2003
Regulation of Cytokine Secretion and Amyloid Precursor Protein Processing by Proinflammatory Amyloid Beta (Aβ)
2000
Interleukin-1 involvement in the induction of leukemia inhibitory factor mRNA expression following axotomy of sympathetic ganglia
1996
Interleukin-1β increases leukemia inhibitory factor mRNA levels through transient stimulation of transcription rate
1996
Cellular development of a nematode: 3-D computer reconstruction of living embryos
1984
Effects of Antipsychotic Drugs on Ito, INa, Isus, IK1, and hERG: QT Prolongation, Structure Activity Relationship, and Network Analysis
2006
Amantadine for weight gain associated with olanzapine treatment
2004
Evaluation of Insulin Sensitivity in Healthy Volunteers Treated with Olanzapine, Risperidone, or Placebo: A Prospective, Randomized Study Using the Two-Step Hyperinsulinemic, Euglycemic Clamp
2003
Lipopolysaccharide induces substance P in sympathetic ganglia via ganglionic interleukin-1 production
1994
Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab
2011
Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients
2015
Efficacy and Safety of Intravenous Solanezumab in Patients with Mild to Moderate Alzheimer's Disease: Results of Two Phase 3 Studies
2013